What is Altimmune, Inc. Common Stock's Market Cap?

Altimmune, Inc. Common Stock's Market Cap is $653.6M, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's Enterprise Value?

Altimmune, Inc. Common Stock's Enterprise Value is $362.0M, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's Price / Sales?

Altimmune, Inc. Common Stock's Price / Sales is 15941.0×, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's EV / Revenue?

Altimmune, Inc. Common Stock's EV / Revenue is 8830.3×, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's EV / EBITDA?

Altimmune, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's Revenue (TTM)?

Altimmune, Inc. Common Stock's Revenue (TTM) is $41.0K, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's Net Income (TTM)?

Altimmune, Inc. Common Stock's Net Income (TTM) is -$91.8M, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's EBITDA?

Altimmune, Inc. Common Stock's EBITDA is -$100.1M, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's Diluted EPS (TTM)?

Altimmune, Inc. Common Stock's Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.

What is Altimmune, Inc. Common Stock's EBITDA Margin?

Altimmune, Inc. Common Stock's EBITDA Margin is -244209.8%, based on as-reported figures from SEC (XBRL) filings.

Altimmune, Inc. Common Stock (ALT) Financial Statements

Altimmune, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SNS461

XNAS · usd

3.36▼ 0.06 (-1.75%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close3.42

Day's Range3.34 – 3.55

52-Week Range2.56 – 6.44

Volume3.6M

Avg Volume4.9M

Share Statistics

Shares Outstanding

Employees57

ExchangeXNAS

Listed2005-10-06

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Altimmune, Inc. Common Stock (ALT)

What is Altimmune, Inc. Common Stock's Market Cap?: Altimmune, Inc. Common Stock's Market Cap is $653.6M, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's Enterprise Value?: Altimmune, Inc. Common Stock's Enterprise Value is $362.0M, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's Price / Sales?: Altimmune, Inc. Common Stock's Price / Sales is 15941.0×, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's EV / Revenue?: Altimmune, Inc. Common Stock's EV / Revenue is 8830.3×, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's EV / EBITDA?: Altimmune, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's Revenue (TTM)?: Altimmune, Inc. Common Stock's Revenue (TTM) is $41.0K, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's Net Income (TTM)?: Altimmune, Inc. Common Stock's Net Income (TTM) is -$91.8M, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's EBITDA?: Altimmune, Inc. Common Stock's EBITDA is -$100.1M, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's Diluted EPS (TTM)?: Altimmune, Inc. Common Stock's Diluted EPS (TTM) is -0.47, based on as-reported figures from SEC (XBRL) filings.
What is Altimmune, Inc. Common Stock's EBITDA Margin?: Altimmune, Inc. Common Stock's EBITDA Margin is -244209.8%, based on as-reported figures from SEC (XBRL) filings.